J

Jing Wang

Shanghai Jiao Tong University

ORCID: 0000-0003-0012-7426

Publishes on CRISPR and Genetic Engineering, PARP inhibition in cancer therapy, Telomeres, Telomerase, and Senescence. 99 papers and 3.5k citations.

PubIndex Score63Top 37% · mid-careerHow it's scored

99Publications

3.5kTotal Citations

First publication: 1998First senior author: 2022

CRISPR and Genetic Engineering PARP inhibition in cancer therapy Telomeres, Telomerase, and Senescence BRCA gene mutations in cancer RNA Interference and Gene Delivery

Top publicationsby citations

Myc activates telomerase

Jing Wang, Gregory J. Hannon, David Beach et al.|Genes & Development|1998

Cited by 659

Glycolytic Enzymes Can Modulate Cellular Life Span

Hiroshi Kondoh, David Beach, Amancio Carnero et al.|Cancer Research|2005

Cited by 640

Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing

Shin‐Heng Chiou, Monte M. Winslow, Seung K. Kim et al.|Genes & Development|2015

Cited by 278

Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation

Xiaosong Huang, Linzhao Cheng, Laurel Mendelsohn et al.|Stem Cells|2015

Cited by 189

Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene

Muhammad Khairul Ramlee, Shang Li, Wei Hong Toh et al.|Genes|2016

Cited by 151